Catherine Gray, director of the US Food and Drug Administration’s Office of Prescription Drug Promotion, cleared up a question some sponsors have about comparative claims in product advertisements when she noted that the agency is, in fact, paying attention to them.
During the Food and Drug Law Institute’s 13-14 October conference on advertising & promotion for medical products, a panel moderator alluded to a comment FDA’s Janet Woodcock made a few years ago